Formoterol Fumarate

adrenoceptor beta 2 ; Homo sapiens







95 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35054851 The Dual Role of the β2-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple Sclerosis. 2022 Jan 8 1
2 33376135 Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting β 2-Adrenoceptor Agonist Combination Therapy in Asthma. 2021 Mar 1
3 30753866 Formoterol counteracts the inhibitory effect of cigarette smoke on glucocorticoid-induced leucine zipper (GILZ) transactivation in human bronchial smooth muscle cells. 2019 May 5 1
4 30834155 β2-Adrenergic receptor (β2-AR) agonist formoterol suppresses differentiation of L6 myogenic cells by blocking PI3K-AKT pathway. 2019 Feb 3
5 29653961 Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. 2018 Jul 2
6 27916196 Adaptive Activation of a Stress Response Pathway Improves Learning and Memory Through Gs and β-Arrestin-1-Regulated Lactate Metabolism. 2017 Apr 15 1
7 28383629 IP-10 in occupational asthma: review of the literature and case-control study. 2017 Mar-Apr 1
8 28874749 Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol. 2017 Sep 5 4
9 26578688 The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion. 2016 Mar 3
10 26595367 Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist. 2016 Apr 15 1
11 25799096 ASM-024, a piperazinium compound, promotes the in vitro relaxation of β2-adrenoreceptor desensitized tracheas. 2015 1
12 26153273 Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes. 2015 Sep 1
13 24705868 Dual regulation of β2-adrenoceptor messenger RNA expression in human lung fibroblasts by β2-cAMP signaling; delayed upregulated inhibitors oppose a rapid in onset, direct stimulation of gene expression. 2014 Jul 1
14 24733958 The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro. 2014 1
15 25328383 Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma. 2014 1
16 23397367 Fluticasone propionate/formoterol fumarate: a review of its use in persistent asthma. 2013 Feb 2
17 22024920 Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study. 2012 Jan 1 1
18 22192974 Cardiac beta-2 adrenoceptor responses to formoterol and associated corticosteroid interactions. 2012 Jan 1
19 22372570 Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms. 2012 Aug 1
20 22383665 ADRB2 polymorphisms and budesonide/formoterol responses in COPD. 2012 Aug 1
21 22659538 Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action. 2012 Aug 1
22 23186269 Differential effects of formoterol on thrombin- and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells. 2012 Nov 27 4
23 27933599 Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma : A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. 2012 Jan 1
24 21134482 The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor. 2011 Apr 1
25 21306583 Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms. 2011 Jun 2
26 21357659 Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol. 2011 Jun 1
27 21917560 Agonist- and hydrogen peroxide-mediated oxidation of the β2 adrenergic receptor: evidence of receptor s-sulfenation as detected by a modified biotin-switch assay. 2011 Dec 1
28 20003162 Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells. 2010 Mar 1
29 20423350 Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. 2010 May 1
30 20590599 The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors. 2010 Jul 1
31 19430548 Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. 2009 Apr 30 2
32 19719779 Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. 2009 Sep 1
33 17901197 Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. 2008 Jan 1
34 18023995 Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. 2008 Feb 2
35 18155275 Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells. 2008 Mar 1
36 18586957 Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. 2008 Sep 1
37 17983258 Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. 2007 3
38 16022567 Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease. 2005 Jul 1
39 14662724 Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. 2004 Jan 5
40 14678342 The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. 2004 Jan 1
41 14725487 Arformoterol: (R,R)-eformoterol, (R,R)-formoterol, arformoterol tartrate, eformoterol-sepracor, formoterol-sepracor, R,R-eformoterol, R,R-formoterol. 2004 4
42 15139778 Formoterol dry-powder inhalation--Novartis/SkyePharma: Foradil MDDPI, Foradil MDPI, Foradil SkyeHaler, formoterol fumarate dry-powder inhalation. 2004 2
43 15145339 Mitochondrial dysfunction and rod-like lesions associated with administration of beta2 adrenoceptor agonist formoterol. 2004 Jun 2
44 15182210 Redefining treatment in COPD: new directions in bronchodilator therapy. 2004 1
45 15324892 Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the beta2-adrenoceptor activity. 2004 Sep 20 1
46 15350154 A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. 2004 1
47 15598475 Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. 2004 Oct 1
48 12513109 Formoterol delivered by Turbuhaler: in pediatric asthma. 2003 1
49 12637127 An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease. 2003 Jan 1
50 12090787 Biological actions of formoterol isomers. 2002 2